Detalhe da pesquisa
1.
Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia.
Haematologica
; 104(1): 147-154, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30115656
2.
Frontline low-dose alemtuzumab with fludarabine and cyclophosphamide prolongs progression-free survival in high-risk CLL.
Blood
; 123(21): 3255-62, 2014 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-24735962
3.
Donor versus no-donor comparison of newly diagnosed myeloma patients included in the HOVON-50 multiple myeloma study.
Blood
; 119(26): 6219-25; quiz 6399, 2012 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-22442350
4.
Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial.
Haematologica
; 99(1): 148-54, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23996482
5.
A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma.
Blood
; 115(6): 1113-20, 2010 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-19880501
6.
Towards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab.
Haematologica
; 96(2): 284-90, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21109694
7.
Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival.
Haematologica
; 100(12): e508-10, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26341740
8.
Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients.
Haematologica
; 100(3): e90-2, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25425692
9.
CT and 18F-FDG PET for noninvasive detection of splenic involvement in patients with malignant lymphoma.
AJR Am J Roentgenol
; 192(3): 745-53, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19234273
10.
A dutch family with Hb Debrousse: severe anemia after parvovirus B19 infection.
Hemoglobin
; 33(3): 269-73, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19657843
11.
Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma.
Haematologica
; 93(1): 124-7, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18166796
12.
Obinutuzumab pretreatment abrogates tumor lysis risk while maintaining undetectable MRD for venetoclax + obinutuzumab in CLL.
Blood Adv
; 2(24): 3566-3571, 2018 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30552161
13.
The HOVON68 CLL trial revisited: performance status and comorbidity affect survival in elderly patients with chronic lymphocytic leukemia.
Leuk Lymphoma
; 58(3): 594-600, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27484290
14.
Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia.
Leuk Lymphoma
; 58(10): 2356-2362, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28278728
15.
Dose-finding study of high-dose simvastatin combined with standard chemotherapy in patients with relapsed or refractory myeloma or lymphoma.
Haematologica
; 91(4): 542-5, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16585018
16.
Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65/ GMMG-HD4 trial.
J Clin Oncol
; 30(24): 2946-55, 2012 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22802322
17.
On the added value of baseline FDG-PET in malignant lymphoma.
Mol Imaging Biol
; 12(2): 225-32, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19809855
18.
Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 Study.
J Clin Oncol
; 28(19): 3160-6, 2010 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20516439
19.
Analysis of efficacy and prognostic factors of lenalidomide treatment as part of a Dutch compassionate use program.
Clin Lymphoma Myeloma Leuk
; 10(2): 138-43, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20371448
20.
Hypocalcemic tetany as an early sign of DiGeorge syndrome in an adult woman.
Am J Med
; 112(2): 161-2, 2002 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11835963